Alterity Therapeutics (ATHE) Change in Receivables (2009 - 2020)
Alterity Therapeutics (ATHE) posted quarterly Change in Receivables of $898621.0 for Q2 2020, up 176.49% year-over-year from $325005.1 in Q3 2019, and up 144.59% quarter-over-quarter from -$2.0 million in Q4 2019.
Alterity Therapeutics (ATHE) Change in Receivables (2009 - 2020) Analysis & Trends
Alterity Therapeutics' Change in Receivables history runs 11 years deep, the most recent figure standing at $898621.0 for Q2 2020.
- In Q2 2020, Change in Receivables rose 176.49% year-over-year to $898621.0; the TTM figure through Jun 2020 stood at -$542814.8 (up 15.57% YoY), while the FY2025 annual figure was $66648.6, down 97.81% from the prior year.
- Change in Receivables for Q2 2020 stood at $898621.0, up from -$2.0 million in the prior quarter.
- The five-year high for Change in Receivables was $1.7 million in Q4 2018, with the low at -$2.2 million in Q4 2016.
- The 5-year median for Change in Receivables is -$884.5 (2018), against an average of -$150911.9.
- The sharpest annual moves came in 2018 and 2019: Change in Receivables jumped 243.82% in 2018, then plunged 132715.6% in 2019.
- Alterity Therapeutics' Change in Receivables stood at -$2.2 million in 2016, then surged by 44.88% to -$1.2 million in 2017, then surged by 243.82% to $1.7 million in 2018, then plunged by 215.25% to -$2.0 million in 2019, then surged by 144.59% to $898621.0 in 2020.
- Business Quant data shows ATHE's Change in Receivables at $898621.0 in Q2 2020, -$2.0 million in Q4 2019, and -$1.2 million in Q2 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 140.20 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 838.50 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -53.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 117.58 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 31.60 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 94.29 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 37.16 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Alterity Therapeutics | 48.56 Mn | 16.26 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2020 | 898,621.00 |
| Jun 30, 2020 | 898,621.00 |
| Dec 31, 2019 | -2.02 Mn |
| Dec 31, 2019 | -2.02 Mn |
| Jun 30, 2019 | -1.17 Mn |
| Jun 30, 2019 | -1.17 Mn |
| Dec 31, 2018 | 1.75 Mn |
| Dec 31, 2018 | 1.75 Mn |
| Jun 30, 2018 | -884.50 |
| Jun 30, 2018 | -884.50 |
| Dec 31, 2017 | -1.22 Mn |
| Dec 31, 2017 | -1.22 Mn |
| Jun 30, 2017 | 1.31 Mn |
| Jun 30, 2017 | 1.31 Mn |
| Dec 31, 2016 | -2.21 Mn |
| Dec 31, 2016 | -2.21 Mn |
| Jun 30, 2016 | 1.30 Mn |
| Jun 30, 2016 | 1.30 Mn |
| Dec 31, 2015 | -1.96 Mn |
| Dec 31, 2015 | -1.96 Mn |